Galmed Pharmaceuticals Ltd. (EOCN): Depreciation & Amortization
$83.0K
Year ended 2024-12-31
+25.5%
3-year compound annual growth
+18.9%
5-year compound annual growth
+24.9%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $83.0K | +167.7% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $31.0K | -11.4% | 2026-03-31, From 2023-01-01 |
| 2022-12-31 | $35.0K | -16.7% | 2025-04-02, From 2022-01-01 |
| 2021-12-31 | $42.0K | +7.7% | 2024-04-04, From 2021-01-01 |
| 2020-12-31 | $39.0K | +11.4% | 2023-03-29, From 2020-01-01 |
| 2019-12-31 | $35.0K | -91.0% | 2022-05-02, From 2019-01-01 |
| 2018-12-31 | $387.0K | +61.9% | 2021-03-18, From 2018-01-01 |
| 2017-12-31 | $239.0K | +41.4% | 2020-03-12, From 2017-01-01 |
| 2016-12-31 | $169.0K | +238.0% | 2019-03-13, From 2016-01-01 |
| 2015-12-31 | $50.0K | +455.6% | 2018-03-13, From 2015-01-01 |
| 2014-12-31 | $9.0K | +125.0% | 2017-03-23, From 2014-01-01 |
| 2013-12-31 | $4.0K | -20.0% | 2016-03-22, From 2013-01-01 |
| 2012-12-31 | $5.0K | n/a | 2015-03-31, From 2012-01-01 |